Entacapone is a catechol-O-methyltransferase (COMT) inhibitor used in the treatment of Parkinson's disease. Its primary pharmacological effects include:
Mechanism of Action: Entacapone works by inhibiting the enzyme catechol-O-methyltransferase (COMT). This enzyme is involved in the breakdown of catecholamines such as dopamine. By inhibiting COMT, entacapone increases the duration of action of levodopa, a precursor to dopamine, thereby enhancing its availability in the brain.